LISA A BOARDMAN, M.D.
Osteopathic Medicine at 1 St, Rochester, MN
License number
Minnesota 35580
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Organization information
See more information about LISA A BOARDMAN at bizstanding.comLisa Boardman MD
200 1 St SW, Rochester, MN 55905
Industry:
Gastroenterology, Internist
Site:
Phone:
(800) 660-4582 (Phone)
Lisa Allyn Boardman
Mayo Clinic - Lisa Boardman MD
200 1 St SW #W4, Rochester, MN 55905
Categories:
Gastroenterology Physicians & Surgeons, Government Contractors
Phone:
(507) 284-2511 (Phone)
Professional information
Lisa A Boardman, Rochester MN
Specialties:
Gastroenterologist
Address:
200 1St St Sw, Rochester, MN 55905
Education:
Wake Forest University, School of Medicine - Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)*
Lisa Allyn Boardman, Rochester MN
Specialties:
Gastroenterology, Hepatology
Work:
Mayo Clinic
200 1St St Sw, Rochester, MN 55905
200 1St St Sw, Rochester, MN 55905
Education:
Wake Forest University (1991) Gastroenterology
Dr. Lisa A Boardman, Rochester MN - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Gastroenterology, 1999, Internal Medicine, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Bowman Gray School Of Medicine
Graduated: 1991
Mayo Grad School Med/mayo Fndn
University Of Fl College Of Med
Bowman Gray School Of Medicine
Graduated: 1991
Mayo Grad School Med/mayo Fndn
University Of Fl College Of Med
Nucleic Acid Sequences Differentially Expressed In Cancer Tissue
US Patent:
2006017, Aug 10, 2006
Filed:
Jul 26, 2005
Appl. No.:
11/190172
Inventors:
Christopher Burgess - Westwood MA, US
Jon Astle - Taunton MA, US
Eddie Carroll - Waltham MA, US
Theodore Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Gary Molino - Norfolk MA, US
Arunthathi Thiagalingam - Lexington MA, US
Marcia Lewis - Cohasset MA, US
Stephen Thibodeau - Rochester MN, US
Lawrence Burgart - Rochester MN, US
Lisa Boardman - Rochester MN, US
Jon Astle - Taunton MA, US
Eddie Carroll - Waltham MA, US
Theodore Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Gary Molino - Norfolk MA, US
Arunthathi Thiagalingam - Lexington MA, US
Marcia Lewis - Cohasset MA, US
Stephen Thibodeau - Rochester MN, US
Lawrence Burgart - Rochester MN, US
Lisa Boardman - Rochester MN, US
International Classification:
A01K 67/027, C07K 14/82, C12Q 1/68, C07H 21/04, C12P 21/06
US Classification:
800011000, 435006000, 435069100, 435320100, 435325000, 530350000, 536023500
Abstract:
This invention relates to novel nucleic acid sequences which are differentially expressed in cancer cells. The invention also relates to proteins and peptides encoded by the sequences, to diagnostic assays and therapeutic agents based on the sequences and proteins, and to probes, antisense constructs, and antibodies derived from the sequences and proteins or peptides. The subject nucleic acids have been found to be differentially expressed by tumor cells, particularly in colon cancer tissue.
Differential Expression Of Genes In Microsatellite Instability
US Patent:
2006013, Jun 22, 2006
Filed:
Apr 13, 2005
Appl. No.:
11/105233
Inventors:
Christopher Burgess - Westwood MA, US
Theodore Catino - Attleboro MA, US
Gary Molino - Norfolk MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Marcia Lewis - Cohasset MA, US
Stephen Thibodeau - Rochester MN, US
Lisa Boardman - Rochester MN, US
Lawrence Burgart - Rochester MN, US
Theodore Catino - Attleboro MA, US
Gary Molino - Norfolk MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Marcia Lewis - Cohasset MA, US
Stephen Thibodeau - Rochester MN, US
Lisa Boardman - Rochester MN, US
Lawrence Burgart - Rochester MN, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
The present invention relates to nucleic acid sequences which are overexpressed in colorectal tumors which display a high level of microsatellite instability (MSI-H) vs. tumors displaying a low level of microsatellite instability (MSS), and can thus be used to identify MSI-H in a patient, and be used further to facilitate patient prognosis, monitor disease progression/regression, identify appropriate treatment regimes, and evaluate the efficacy of treatment.
Detection Methods Using Timp 1
US Patent:
2004015, Aug 12, 2004
Filed:
Dec 12, 2003
Appl. No.:
10/734564
Inventors:
Jon Astle - Taunton MA, US
Christopher Burgess - Westwood MA, US
Theodore Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Maryanne Huntress - Attleboro MA, US
Karen Johnson - Acton MA, US
Marcia Lewis - Cohasset MA, US
Peter Maimonis - Westwood MA, US
Gary Molino - Norfolk MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Lisa Boardman - Rochester MN, US
Lawrence Burgart - Rochester MN, US
Stephen Thibodeau - Rochester MN, US
Christopher Burgess - Westwood MA, US
Theodore Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Maryanne Huntress - Attleboro MA, US
Karen Johnson - Acton MA, US
Marcia Lewis - Cohasset MA, US
Peter Maimonis - Westwood MA, US
Gary Molino - Norfolk MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Lisa Boardman - Rochester MN, US
Lawrence Burgart - Rochester MN, US
Stephen Thibodeau - Rochester MN, US
International Classification:
G01N033/567, G01N033/574
US Classification:
435/007230
Abstract:
The present invention relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1 or TIMP1 nucleic acid or amino acid molecules in a clinical sample obtained from the patient, wherein Reg1 or TIMP1 expression is indicative of the presence of colorectal cancer. The invention further relates to a method for detecting the presence of colorectal cancer in an individual, wherein colorectal cancer is detected by detecting the presence of Reg1 or TIMP1 nucleic acid or amino acid molecules in a clinical sample, in addition to detecting the presence of one or more additional colorectal cancer associated markers.
Novel Human Genes And Gene Expression Products
US Patent:
2004014, Jul 29, 2004
Filed:
Jun 30, 2003
Appl. No.:
10/610049
Inventors:
Jon Astle - Taunton MA, US
Lisa Boardman - Rochester MN, US
Lawrence Burgart - Rochester MN, US
Christopher Burgess - Westwood MA, US
Theodore Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Marcia Lewis - Cohasset MA, US
Gary Molino - Norfolk MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Stephen Thibodeau - Rochester MN, US
Lisa Boardman - Rochester MN, US
Lawrence Burgart - Rochester MN, US
Christopher Burgess - Westwood MA, US
Theodore Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Marcia Lewis - Cohasset MA, US
Gary Molino - Norfolk MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Stephen Thibodeau - Rochester MN, US
International Classification:
C12Q001/68, G01N033/574
US Classification:
435/006000, 435/007230
Abstract:
This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.
Human Genes And Gene Expression Products: Ii
US Patent:
7211398, May 1, 2007
Filed:
Oct 25, 2002
Appl. No.:
10/280403
Inventors:
Jon H. Astle - Taunton MA, US
Christopher C. Burgess - Westwood MA, US
Theodore J. Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Marcia E. Lewis - Cohasset MA, US
Gary A. Molino - Norfolk MA, US
Susan H. Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Stephen Thibodeau - Rochester MN, US
Lawrence J. Burgart - Rochester MN, US
Lisa Allyn Boardman - Rochester MN, US
Christopher C. Burgess - Westwood MA, US
Theodore J. Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Marcia E. Lewis - Cohasset MA, US
Gary A. Molino - Norfolk MA, US
Susan H. Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Stephen Thibodeau - Rochester MN, US
Lawrence J. Burgart - Rochester MN, US
Lisa Allyn Boardman - Rochester MN, US
Assignee:
Bayer Corporation - Tarrytown NY
Mayo Foundation for Medical Education and Research - Rochester MN
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.
Method For Detecting A Differentially Expressed Sequence
US Patent:
7258973, Aug 21, 2007
Filed:
Jul 17, 2001
Appl. No.:
09/907479
Inventors:
Jon H. Astle - Taunton MA, US
Christopher C. Burgess - Westwood MA, US
Theodore J. Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Marcia E. Lewis - Cohasset MA, US
Gary A. Molino - Norfolk MA, US
Susan H. Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Stephen Thibodeau - Rochester MN, US
Lawrence J. Burgart - Rochester MN, US
Lisa Allyn Boardman - Rochester MN, US
Christopher C. Burgess - Westwood MA, US
Theodore J. Catino - Attleboro MA, US
Poornima Dwivedi - Alamo CA, US
Marcia E. Lewis - Cohasset MA, US
Gary A. Molino - Norfolk MA, US
Susan H. Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Stephen Thibodeau - Rochester MN, US
Lawrence J. Burgart - Rochester MN, US
Lisa Allyn Boardman - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education & Research - Rochester MN
Bayer Healthcare, LLC - Tarrytown NY
Bayer Healthcare, LLC - Tarrytown NY
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
This invention relates to novel human genes, to proteins expressed by the genes, and to variants of the proteins. The invention also relates to diagnostic assays and therapeutic agents related to the genes and proteins, including probes, antisense constructs, and antibodies. The subject nucleic acids have been found to be differentially regulated in tumor cells, particularly in colon cancer tissue.
Use Of Differentially Expressed Nucleic Acid Sequences As Biomarkers For Cancer
US Patent:
2008023, Sep 25, 2008
Filed:
Mar 13, 2008
Appl. No.:
12/047358
Inventors:
Christopher Burgess - Westwood MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Peter Maimonis - Westwood MA, US
Gary Molino - Norfolk MA, US
Lawrence Burgart - Rochester MN, US
Lisa Allyn Boardman - Rochester MN, US
Stephen Thibodeau - Rochester MN, US
Marcia Lewis - Cohasset MA, US
Susan Myerow - Lexington MA, US
Arunthathi Thiagalingam - Lexington MA, US
Peter Maimonis - Westwood MA, US
Gary Molino - Norfolk MA, US
Lawrence Burgart - Rochester MN, US
Lisa Allyn Boardman - Rochester MN, US
Stephen Thibodeau - Rochester MN, US
Marcia Lewis - Cohasset MA, US
International Classification:
C12Q 1/68, C07K 16/18, G01N 33/53
US Classification:
435 6, 530350, 5303879, 435 721
Abstract:
The present invention relates to novel marker sequences that are differentially expressed in cancer cells or tissue of a subject with cancerous conditions. The present invention also relates to assays for diagnosis, prognosis, staging, monitoring, therapeutic treatment, and marker sequence related agents including probes, primers, antibodies, and therapeutic compositions.